RecallDepth
Class III Terminated

treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 packs ABILIFY Tablets 10mg (14 day supply) plus 1 ABILIFY MAINTENA Pre-filled Dual Chamber Syringe Kit. Rx only. Not for sale or reimbursement. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850. Marketed by: Deerfield, IL 60015 USA. Bar Code DCSKit-59148-10Tabs-01

Company
Otsuka Pharmaceutical Development & Commercialization, Inc.
Recall Initiated
September 17, 2018
Posted
October 10, 2018
Recall Number
D-0017-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
17325 kits
Firm Location
Princeton, NJ, United States

Reason for Recall

Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.

Distribution

Nationwide in the US

Lot / Code Info

Lots: 7F92YUD3H1A/AIS1017B, 7F92YUD3H1A/AIS1017C, EXP 30-Jun-2020.

Other recent Class III Drug recalls